InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+4.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Thompson Jeffery S, Director. Officer active across 2 companies, notably Anika Therapeutics, Inc.. Cumulatively, 6 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €45k. Activity tracked since 16 June 2021. The latest transaction was disclosed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations6 total
6,500 shares0Common StockSEC:0001171843-23-003962:0
7,954 shares0Common StockSEC:0001171843-22-004297:0
2,000 shares@ US$24.6590.023% mcap100.0% of flowCommon StockSEC:0001171843-22-001878:0
Ideal exit: 6 Dec 2022 (T+270)
4,172 shares0Common StockSEC:0001171843-21-004430
4,172 shares0Common StockSEC:0001171843-21-004430:0
2,361 sharesCommon StockSEC:0001171843-16-007729:0
6 of 6 declarations
About Thompson Jeffery S
Jeffery S Thompson is a Board Member at Anika Therapeutics, Inc. He contributes to the governance of the company by bringing his expertise and experience to the board. His role is crucial in guiding strategic decisions and ensuring the smooth operation of the company.
